"Low Country Cancer Care is constantly striving to provide advanced treatment and world class medicine in a warm, compassionate, and personalized environment. Our experienced and highly trained team is dedicated to providing the highest-quality diagnosis, treatment, care and trust for our patients. Our goal is to provide unsurpassed care with a human touch."

During the past decade, Low Country Cancer Care conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 28 clinical trials were completed, i.e. on average, 65.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 26 clinical trials were completed. i.e. 1300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Low Country Cancer Care" #1 sponsor was "National Cancer Institute (NCI)" with 23 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "GOG Foundation" with 5 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Low Country Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 31 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Low Country Cancer Care" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Stage IIIA Breast Cancer" (4 trials), "Cervical Adenocarcinoma" (3 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Low Country Cancer Care" in a lesser frequency.

Most popular intervention types in "Low Country Cancer Care" are "Other" (42 trials), "Drug" (41 trials), "Biological" (22 trials), "Procedure" (13 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (29 trials), "Quality-of-Life Assessment" (14 trials), "Docetaxel" (9 trials), "Carboplatin" (8 trials) and "Nivolumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "Low Country Cancer Care" are 46 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "Low Country Cancer Care". undefined are not yet recruiting, 6 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Low Country Cancer Care, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Low Country Cancer Care, 1 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".